[ad_1] MILWAUKEE, Dec. 15, 2025 /PRNewswire/ — The Ademi Firm is investigating Generation Bio (Nasdaq: GBIO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XOMA Royalty Corporation. […]
Tag: Ademi LLP
The Ademi Firm investigates whether Alexander & Baldwin, Inc. is obtaining a Fair Price for its Public Shareholders
[ad_1] MILWAUKEE, Dec. 8, 2025 /PRNewswire/ — The Ademi Firm is investigating Alexander & Baldwin (NYSE: ALEX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with MW Group […]
The Ademi Firm investigates whether Synchronoss Technologies Inc. is obtaining a Fair Price for its Public Shareholders
[ad_1] MILWAUKEE, Dec. 5, 2025 /PRNewswire/ — The Ademi Firm is investigating Synchronoss (NASDAQ: SNCR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lumine Group. Click here […]
The Ademi Firm continues to investigate whether Comerica Incorporated is obtaining a Fair Price for its Public Shareholders
[ad_1] MILWAUKEE, Dec. 2, 2025 /PRNewswire/ — The Ademi Firm continues to investigate Comerica (NYSE: CMA) for possible breaches of fiduciary duty and other violations of law in its transaction with Fifth Third. Click here […]
The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
[ad_1] MILWAUKEE, Nov. 14, 2025 /PRNewswire/ — The Ademi Firm is investigating Repare (Nasdaq: RPTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XenoTherapeutics, Inc. Click […]
